OCT 23, 2017 3:06 PM PDT

Court Overturns $417M Talc Cancer Verdict

WRITTEN BY: Xuan Pham

Image credit:  Lucas Jackson / Reuters

The record verdicts to award millions of dollars in damages associated with Johnson & Johnson’s baby powder has been overturned. Courts have instead ruled on the side of Johnson & Johnson, dealing harsh blows to two women who had previously been awarded $417 million and $72 million, separately.

In the first case, judges overturned a ruling in August that awarded $70 million in compensatory damages and another $347 million in punitive damages to 63-year-old Eva Echeverria. A long-time user of Johnson & Johnson’s talcum powder for feminine hygiene purposes, Echeverria developed ovarian cancer, a disease which she believed to be caused by the powder product. In court, her lawyers alleged that Johnson & Johnson had known about such cancer link for some time, but had failed to adequately warn consumers of the product’s risks.

“Mrs. Echeverria is dying from this ovarian cancer and she said to me all she wanted to do was to help the other women throughout the whole country who have ovarian cancer for using Johnson & Johnson for 20 and 30 years,” said Mark Robinson, Echeverria’s attorney. “She really didn’t want sympathy. She just wanted to get a message out to help these other women.”

"Johnson & Johnson had many warning bells over a 30 year period but failed to warn the women who were buying its product," said Robinson.

But the Los Angeles Superior Court Judge Maren Nelson, who presided over Johnson & Johnson’s appeal, found an “insufficiency of the evidence as to the causation as to both defendants." In addition, the judge also found trial errors and jury misconduct, which contributed to inflation of the compensation amount.

In response to the verdict reversal, Robinson said, "We disagree with the court's decision. A jury of Ms. Echeverria's peers found the Johnson and Johnson defendants liable. We will ask the appellate court to uphold this jury's verdict. We will continue to fight on behalf of all women who have been impacted by this dangerous product."

In the second case, a Missouri appellate court overturned a $72 million payout to Jacqueline Fox, another woman who also sued the pharmaceutical giant for cancer related to talcum powder use. The court’s decision to reverse the verdict was grounded on the notion that Fox’s claims did not "arise out of J&J's activities in Missouri." In other words, the case shouldn’t have been tried in Missouri.

"We are pleased with Judge Maren Nelson's ruling. Ovarian cancer is a devastating disease -- but it is not caused by the cosmetic-grade talc we have used in Johnson's Baby Powder for decades," said Carol Goodrich, a spokeswoman for Johnson & Johnson Consumer. "The science is clear and we will continue to defend the safety of Johnson's Baby Powder as we prepare for additional trials in the U.S."

Additional sources: CNN

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
SEP 02, 2021
Immunology
Hobit Activates Cancer-Killing Immune Cells
SEP 02, 2021
Hobit Activates Cancer-Killing Immune Cells
Innate lymphoid cells, or ILCs, are specialized immune cells that are increasingly entering the research spotlight. Thes ...
SEP 23, 2021
Drug Discovery & Development
The FDA approves the first and only oral treatment for a certain non-small cell lung cancer.
SEP 23, 2021
The FDA approves the first and only oral treatment for a certain non-small cell lung cancer.
Last week, the United States Food and Drug Administration (FDA) granted approval for the first oral therapy to ...
NOV 05, 2021
Cancer
The Labroots 2021 Cancer Research and Oncology Virtual Event Poster Winner
NOV 05, 2021
The Labroots 2021 Cancer Research and Oncology Virtual Event Poster Winner
Every year, Labroots hosts an exciting series of Virtual Events that focus on various scientific topics. These virtual m ...
NOV 08, 2021
Drug Discovery & Development
A case study of CBD's tumor shrinking potential
NOV 08, 2021
A case study of CBD's tumor shrinking potential
A recent article published in the British Medical Journal reported the case of a woman who shrank a tumor by taking CBD. ...
DEC 18, 2021
Cell & Molecular Biology
How the HTLV-1 Virus Can Turn Immune Cells Cancerous
DEC 18, 2021
How the HTLV-1 Virus Can Turn Immune Cells Cancerous
In some cases, viruses have been linked to cancer. For example, HPV, which is now preventable with a vaccine, can lead t ...
JAN 13, 2022
Cancer
An Arthritis Drug Combats Chemoresistance in Pancreatic Cancer
JAN 13, 2022
An Arthritis Drug Combats Chemoresistance in Pancreatic Cancer
The American Cancer Society estimates the lifetime risk of pancreatic cancer at about 1 in 64. Pancreatic duct ...
Loading Comments...